Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 6, 2021; 9(31): 9406-9416
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9406
Table 4 Comparison of demographic and clinical characteristics for deep venous thrombosis after artificial liver support system stage II, n (%)
Parameters
DVT (n = 14)
No-DVT (n = 199)
Statistics
P value
Gender
Man9 (64.3)165 (82.9)3.0350.082
Woman5 (35.7)34 (17.1)
Age (yrs)
< 402 (16.7)51 (25.6)11.0040.004
< 60, ≥ 402 (16.7)101 (50.8)
≥ 608 (66.7)47 (23.6)
Catheterization mode
Jugular vein 2 (14.3)51 (25.6)0.9030.343
Femoral vein 12 (85.7)148 (74.4)
Times of successful catheterization
One3 (21.4)120 (60.3)13.7420.001
Two4 (28.6)51 (25.6)
Three and more7 (50.0)28 (14.1)
ALSS times
< 34 (28.6)61 (30.7)9.2070.01
≥ 3, < 55 (35.7)119 (50.8)
≥ 55 (35.7)19 (9.5)
Activity status
Free activities0 (0)23 (11.6)11.7610.008
Less than 4 h/d4 (28.6)69 (34.7)
Less than 1 h/d4 (28.6)84 (42.6)
Strict bed rest6 (42.9)23 (11.6)
Infection
No4 (28.6)114 (57.6)4.3650.037
Yes10 (71.4)85 (42.4)
D-dimer (ng/mL)
< 2001 (7.1)65 (32.7)14.840.001
≥ 200, < 5004 (28.6)94 (47.2)
≥ 5009 (64.3)40 (20.1)